Large-format lithium-ion battery maker Ener1, Inc. today announced that it has received $20 million in fresh investment capital from ITOCHU Corporation, a Japanese commercial trading giant with deep ties in the automotive, utility and renewable energy industries.
Merrimack Pharmaceuticals, Inc., announced today that it has acquired Hermes Biosciences, Inc. a private biotechnology company based in South San Francisco, California. Hermes specializes in targeted drug delivery technologies for therapeutic and other biomedical applications using lipidic nano-carriers and antibodies as targeting agents.
Utilizing a state-of-the-art CCD detector containing over three million detector elements, Mie theory, and unique design and data reduction features, the Saturn DigiSizer II High-Definition Digital Particle Size Analyzer from Micromeritics provides an extremely high level of resolution and sensitivity not available in other laser particle sizing systems.
The Institute of Physics (IOP) awarded Dr. Rachel McKendry the prestigious Paterson medal and prize in recognition of her international contributions, and in particular for her work developing label-free nanomechanical cantilever sensors.
Nanocyl announced today it is installing a new reactor with a capacity of 400 metric tons/year for producing its NC 7000 carbon nanotube technologies. The new reactor, scheduled to come online in July 2010, will be located in Sambreville, Belgium.
At the KMIS meeting (Klinisch-Mikrobiologisch-Infektiologisches Symposium) on Dec. 3-5, 2009 in Berlin, Bruker Daltonics announces a framework agreement with Synlab concerning molecular microbial identification based on MALDI-TOF mass spectrometry.
Bruker BioSpin has successfully completed the installation of the world's first 1000 MHz ultra-high field NMR AVANCE spectrometer at the Centre de Resonance Magnetique Nucleaire a Tres Hauts Champs (CRMN) in Lyon, France.
C3-Jian, Inc. and Matrix Sensors, Inc. have announced a collaboration in which engineered peptides from C3-Jian will be used on Matrix Sensors' microchip molecular detector arrays, allowing initial evaluation of a diagnostic assay platform for commercial use.
Brinks Hofer Gilson Lione, one of the largest intellectual property law firms in the U.S., and the NanoBusiness Alliance will jointly present a nanotechnology seminar at Brinks' offices in Chicago on Wednesday, December 9, 2009, from 2:00 p.m. to 5:30 p.m.
The Zetasizer Nano particle characterization system from Malvern Instruments (Malvern, UK) is proving to be an ideal research tool for advanced healthcare applications such as gene therapy and selective-target carrier molecules.
At the recent Licensing Executives Society Annual Meeting in San Francisco, a two-part session on solar energy explored some of the new technologies and offered a forum for discussion on how these technologies could be licensed and implemented.
IDBS, the leading worldwide provider of research data management and analytics solutions to R+D organizations, today announced that L'Institut de Biologie et Chimie des Proteines (IBCP), a principal research institute based in Lyon, France, has selected E-WorkBook Suite to manage its research data and knowledge in developing nanoparticles for the treatment of viral infections.
Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses.